If you're starting testosterone replacement therapy (TRT), one question sits above all others: how much testosterone should you take per week? It's the number everyone wants. But the honest answer is that there's no single "right" weekly dose. The dose is the result of a process, not the starting point. Your doctor picks a reasonable beginning amount, checks your blood, then adjusts until your levels and your symptoms both land where they should.
This guide explains how that process works, what doses real clinics and the FDA-approved labels actually use, and why injection frequency can matter as much as the milligrams themselves. It's written for the beginner who wants to walk into a first appointment already understanding the language.
Medical disclaimer: This article is educational and is not medical advice. It does not give you a dose to take on your own. TRT is a prescription therapy that requires a confirmed diagnosis, a licensed prescriber, and ongoing blood monitoring. Never start, change, or stop testosterone without your doctor. Buying testosterone without a prescription is illegal in the United States and unsafe.
Quick Answer
- There is no universal weekly dose. Most men on injectable TRT are dosed somewhere in the range of 100–200 mg of testosterone cypionate or enanthate per week, but your doctor sets the exact number based on your starting blood levels and how you respond.
- The FDA label for testosterone cypionate lists 50–400 mg every two to four weeks for hypogonadal men (FDA Depo-Testosterone label). Modern clinics usually convert this to smaller, more frequent weekly or twice-weekly shots for steadier levels.
- The goal is a number, not a feeling-by-itself. Major guidelines aim for a mid-normal testosterone level — the AUA targets roughly 450–600 ng/dL — using the lowest dose that gets you there and relieves symptoms (AUA Guideline, 2018).
- Frequency is part of the dose. Splitting the same weekly amount into twice-weekly shots tends to flatten the peaks and troughs and may lower the risk of a thick-blood side effect called erythrocytosis (Endocrine Society, 2018).
Why Isn't There a Single "Correct" TRT Dose?
Think of TRT dosing like adjusting the thermostat in a house you've never lived in. You set it to a sensible starting point. Then you wait, check the actual temperature, and nudge it. The right setting depends on the house, not on a number printed in a manual.
Testosterone works the same way. Two men can take the identical 120 mg per week and end up with very different blood levels. Body size, body fat, how fast your liver clears the drug, how much of your testosterone is bound up by a protein called SHBG — all of it shifts where the same dose lands. That's why the Endocrine Society and the AUA both describe dosing as a process of starting low, measuring, and titrating, rather than a fixed prescription you get on day one (Endocrine Society, 2018).
There's a second reason the "per week" number can mislead beginners. Doses are sometimes written per injection, sometimes per week, and sometimes per two weeks. A man told "200 mg" might be taking 200 mg every two weeks (about 100 mg/week) or 200 mg weekly. Those are very different. When you talk to your provider, always confirm the amount and the time window.
What Does "Normal" Testosterone Even Mean?
You can't aim for a target without knowing the dartboard. A large study that harmonized lab reference ranges across four big population cohorts found that the normal range for healthy, non-obese men aged 19 to 39 runs roughly 264 to 916 ng/dL (Travison et al., 2017). Labs vary, so your own report may print slightly different numbers.
A few key thresholds beginners should know:
| Concept | Typical figure | Source |
|---|---|---|
| Normal total testosterone (men 19–39) | ~264–916 ng/dL | Travison et al., 2017 |
| Diagnostic cutoff for "low" | Below ~300 ng/dL (on two morning tests) | AUA, 2018 |
| Common therapeutic target | Mid-normal, ~450–600 ng/dL | AUA, 2018 |
| Confirm low BEFORE starting | Two separate morning blood draws | FDA label / Endocrine Society |
The AUA guideline uses a total testosterone below 300 ng/dL as a reasonable cutoff to support a diagnosis of testosterone deficiency, and it asks clinicians to use the minimal dose needed to reach the mid-normal range, around 450–600 ng/dL (AUA, 2018). Notice the word minimal. More is not the goal. Enough is the goal.
One more rule that trips people up: diagnosis must be confirmed first. The FDA testosterone cypionate label is explicit that you confirm hypogonadism by measuring serum testosterone in the morning on at least two separate days, with both readings below the normal range, before treatment begins (FDA Depo-Testosterone label). If you're not sure whether you even qualify, our companion guide on low-testosterone symptoms and diagnosis walks through who actually needs TRT.
How Much Testosterone Do Most Men Take Per Week?
Here's the practical picture, drawn from the FDA-approved labels and how modern clinics translate them. Injectable testosterone esters — cypionate and enanthate — are the most common form, so we'll center on those.
The FDA label for testosterone cypionate states that for replacement in the hypogonadal male, 50 to 400 mg should be given every two to four weeks (FDA Depo-Testosterone label). That's a wide window, and it reflects the old once-every-few-weeks style of dosing.
In practice, many clinics moved away from big, infrequent shots. Instead they take a similar total amount and spread it out — often weekly or twice weekly — because smaller, more frequent doses hold your levels steadier. The Endocrine Society notes that giving the same amount more often produces less swing between peak and trough (Endocrine Society, 2018).
Here's roughly how the common forms break down:
| Form | Typical labeled or clinical dosing | Notes |
|---|---|---|
| Testosterone cypionate (IM/SC) | 50–400 mg every 2–4 weeks (FDA); often split to 100–200 mg/week or half twice weekly in practice | Cheapest, most adjustable |
| Testosterone enanthate (IM/SC) | Similar ester to cypionate; subcutaneous auto-injector studied at 50–100 mg weekly | Behaves much like cypionate |
| Testosterone undecanoate (Aveed, IM) | 750 mg, repeat at 4 weeks, then every 10 weeks | In-office only, REMS program |
| Testosterone gel (transdermal) | Applied daily | Steady levels, transfer risk to others |
A clinical example helps anchor the numbers. In a 52-week study of a subcutaneous testosterone enanthate auto-injector, men started at 75 mg weekly, then had the dose adjusted up or down to 50, 75, or 100 mg based on their week-6 trough level. By week 12, about 93% landed in the target range of 300–1,100 ng/dL, with a mean near 553 ng/dL and small peak-to-trough swings (Kaminetsky et al., 2019). That study is a clean illustration of the whole philosophy: start at a standard dose, measure the trough, adjust.
For the longer-acting injectable, testosterone undecanoate (brand Aveed), the FDA label sets a fixed schedule: 750 mg, a second 750 mg dose at four weeks, then 750 mg every ten weeks (Aveed label, DailyMed). It's given in a clinic, not at home, and requires a 30-minute observation period because of a rare lung reaction.
If you want a full comparison of shots versus gels versus pellets, see our deep dive on TRT delivery methods.
Why Does Injection Frequency Matter as Much as the Dose?
This is the part beginners underestimate. The same weekly milligrams can feel and test very differently depending on how often you split them.
Picture two men, each taking 140 mg of testosterone cypionate per week. Man A takes it all in one shot every Monday. Man B takes 70 mg on Monday and 70 mg on Thursday. They get the identical weekly dose. But Man A rides a bigger wave — a high peak a day or two after the shot, then a slow slide to a low trough before the next one. Man B's line is flatter. Less roller coaster.
Why this matters:
- Symptom stability. Big peaks and deep troughs can show up as mood swings, energy dips late in the week, or libido that fades before the next dose.
- Side-effect risk. Higher peaks push your body harder. The most common dose-related side effect is erythrocytosis — your blood gets too thick because the bone marrow makes too many red cells. A systematic review and network meta-analysis found that the route and pattern of testosterone delivery affects how much hematocrit rises, with injectable forms tending to raise it more than gels (Nackeeran et al., Bayesian network meta-analysis, 2022).
- Estrogen swings. Testosterone converts partly to estradiol. Sharp testosterone peaks can drive sharp estradiol peaks for some men, which is part of the conversation in our estrogen management guide.
The Endocrine Society guideline supports the idea that more frequent dosing of a given amount yields steadier levels (Endocrine Society, 2018). Subcutaneous weekly dosing studies reinforce it, showing steady profiles with small fluctuations on once-weekly small doses (Kaminetsky et al., 2019; Gittelman et al., 26-week safety study, 2019).
The takeaway isn't "always inject more often." It's that frequency is a real dial your doctor can turn, separate from total dose, to smooth out levels and manage side effects.
How Is Your Starting Dose Chosen and Adjusted?
The dosing process follows a predictable arc. Knowing it removes a lot of first-appointment anxiety.
| Step | What happens | Rough timing |
|---|---|---|
| 1. Confirm diagnosis | Two morning testosterone draws below range, plus symptoms | Before any prescription |
| 2. Baseline labs | Hematocrit, PSA (age-dependent), estradiol, often others | Before starting |
| 3. Start a standard dose | A conservative, common starting amount | Day 1 |
| 4. Recheck at trough | Blood drawn just before the next dose | ~6 weeks |
| 5. Adjust the dose | Up or down based on trough level + symptoms | After lab review |
| 6. Recheck and stabilize | Confirm target reached, monitor safety labs | ~3, 6, 12 months |
The single most important detail in that table is trough timing. Your levels swing across the week, so where you measure changes the number. Clinics typically draw blood right before your next scheduled shot — the lowest point — so they're checking that even your floor is acceptable. A level drawn the day after an injection can read sky-high and mislead everyone.
The Endocrine Society recommends monitoring testosterone, hematocrit, and other safety markers on a schedule, and adjusting toward the mid-normal range while watching for side effects (Endocrine Society, 2018). For the full monitoring schedule and which labs to expect, see our TRT blood work guide.
One honest caveat for beginners chasing a "feel great" dose: more testosterone is not linearly more benefit. Push past the normal range and you mostly buy side effects, not extra wellbeing. Both the AUA and Endocrine Society frame the target as the minimal dose that restores mid-normal levels and resolves symptoms (AUA, 2018).
What Dose-Related Side Effects Should You Watch For?
Dosing isn't only about hitting a target. It's about staying safe at that target. The dose-sensitive issues your doctor monitors include:
- Erythrocytosis (thick blood). The most common dose-related effect. Higher peaks and higher average levels raise the risk. It's why hematocrit is checked regularly, and why frequency adjustments or dose reductions get used (hematocrit network meta-analysis, 2022).
- Estradiol changes. Some testosterone converts to estrogen; how much varies a lot between men.
- Fertility suppression. Standard TRT signals the brain to stop telling the testicles to make their own testosterone and sperm. If you may want children, this matters — see our guide on TRT and fertility with HCG and enclomiphene.
- Cardiovascular questions. The large TRAVERSE trial found testosterone gel was non-inferior to placebo for major adverse cardiac events in men with low testosterone and high cardiovascular risk, though it noted more cases of certain heart-rhythm issues like atrial fibrillation (Lincoff et al., NEJM 2023).
For a fuller treatment of the safety evidence, read our TRT side effects and safety overview. The point for dosing: side-effect risk generally tracks with how high and how spiky your levels run, which is exactly why the lowest effective dose is the guideline-backed goal.
How Does Dose Affect What TRT Costs?
Dose and frequency quietly drive your monthly bill. Injectable cypionate and enanthate are usually the cheapest forms, and a typical weekly dose uses a small fraction of a multi-dose vial. More frequent self-injection adds a few extra needles and syringes but doesn't meaningfully raise drug cost. By contrast, in-office injections like Aveed add clinic visit and observation fees, and gels often cost more per month than generic injectable vials.
Because the numbers depend on your exact dose, vial concentration, and provider, run your own scenario with our TRT cost calculator. You can also compare what different clinics charge on our compare page or browse vetted TRT providers before you commit.
Frequently Asked Questions
Is 200 mg of testosterone per week a normal TRT dose? It's at the higher end of common TRT dosing and edges toward levels above the physiologic target many guidelines aim for. Some men do end up there based on blood work, but the AUA recommends the minimal dose that reaches roughly 450–600 ng/dL (AUA, 2018). Doses near 200 mg/week and above are also associated with more erythrocytosis. Your trough labs, not a target milligram number, should decide.
Should I inject testosterone once a week or twice a week? Many clinicians split the weekly amount into two shots to flatten peaks and troughs and to ease side effects like thick blood. The same weekly total, divided more often, generally produces steadier levels (Endocrine Society, 2018). Some men do fine on once weekly. It's an individual call your provider makes with your labs.
How long until I know if my dose is right? Expect a recheck around six weeks, drawn at your trough — just before your next dose. That's when clinics adjust up or down. In one structured study, dose was set at week 6 and most men were in range by week 12 (Kaminetsky et al., 2019). Full symptom benefit can take several months.
Can I just take more testosterone to feel even better? No. Past the normal range, you mostly add side effects, not benefit. Guidelines target mid-normal levels with the lowest effective dose (AUA, 2018). Higher doses raise erythrocytosis risk and other problems without reliably improving how you feel.
What's the difference between testosterone cypionate and enanthate dosing? Very little for most patients. They're closely related long-acting esters with similar half-lives and similar dosing, and they're used interchangeably by many clinics. Subcutaneous enanthate auto-injectors have been studied at 50–100 mg weekly with steady results (Kaminetsky et al., 2019). Your choice usually comes down to availability and cost, not a meaningful dosing difference.
Related Guides
- Do I Need TRT? Low-Testosterone Symptoms & How It's Diagnosed
- TRT Blood Work: The Labs & Monitoring Schedule
- TRT Delivery Methods: Injections vs Cream vs Pellets vs Nasal
- Estrogen Management on TRT (and the Anastrozole Debate)
- TRT Side Effects & Safety: What the Evidence Says
- How Much Does TRT Cost? Telehealth vs Clinic vs Insurance
Sources
- Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018. PMID 29562364
- Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018. PMID 29601923
- FDA. Depo-Testosterone (testosterone cypionate) Prescribing Information. FDA label PDF
- FDA. Aveed (testosterone undecanoate) Prescribing Information. DailyMed label
- Kaminetsky JC, et al. A 52-Week Study of Dose Adjusted Subcutaneous Testosterone Enanthate in Oil Self-Administered via Disposable Auto-Injector. J Urol. 2019. PMID 30296416
- Gittelman M, Jaffe JS, Kaminetsky JC. Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study. J Sex Med. 2019. PMID 31551193
- Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med. 2023. PMID 37326322
- Nackeeran S, et al. The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials. J Urol. 2022. PMID 34445892
- Travison TG, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. J Clin Endocrinol Metab. 2017. PMID 28324103
- Endocrine Society. Testosterone Therapy for Hypogonadism Guideline Resources. endocrine.org